Coronavirus disease (COVID-19) is an infectious disease caused by the most recently discovered corona virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease causes respiratory illness (like the flu) with symptoms such as a cough, fever, and difficulty breathing. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elderly people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The COVID-19 virus is primarily transmitted through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. People can catch COVID-19 if they breathe in droplets from a person with COVID-19 who coughs out or exhales droplets. It also spreads when a person touches a surface or objects that has the virus on it, and then touches their eyes, nose, or mouth.
DelveInsight’s, “COVID-19 Pipeline Insight, 2021” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs in COVID-19 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/covid-19-coronavirus-pipeline-insights
Some of the COVID-19 Companies are:
DelveInsight’s COVID-19 report covers around 200+ products under different phases of clinical development like:
Some of COVID-19 Therapies are:
Current COVID-19 Treatment Scenario and COVID-19 Emerging Therapies:
Table of Contents:
Introduction
Executive Summary
COVID-19: Overview
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
COVID-19– DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
• COVID-19 companies’ collaborations, Licensing, Acquisition -Deal Value Trends
COVID-19 Collaboration Deals
Late Stage Products (Phase III)
VERU-111: Veru Inc.
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
CF-101: Can-Fite Biopharma
Early Stage Products (Phase I)
ABBV-47D11: AbbVie
Preclinical and Discovery Stage Products
TNX-1800: Tonix Pharmaceuticals
Inactive Products
COVID-19 Key Companies
COVID-19 Key Products
COVID-19- Unmet Needs
COVID-19- Market Drivers and Barriers
COVID-19- Future Perspectives and Conclusion
COVID-19 Analyst Views
Appendix
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/covid-19-coronavirus-pipeline-insights